CO124 Indirect Comparison of Efficacy and Safety for Aumolertinib vs Osimertinib in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.202
https://www.valueinhealthjournal.com/article/S1098-3015(22)02406-8/fulltext
Title :
CO124 Indirect Comparison of Efficacy and Safety for Aumolertinib vs Osimertinib in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02406-8&doi=10.1016/j.jval.2022.09.202
First page :
Section Title :
Open access? :
No
Section Order :
11644